Cannasouth Ltd
NZX:CBD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.096
0.147
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NZD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Cannasouth Ltd
Cannasouth Ltd
Capital Expenditures
Cannasouth Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cannasouth Ltd
NZX:CBD
|
Capital Expenditures
-NZ$345.2k
|
CAGR 3-Years
-59%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
BLIS Technologies Ltd
NZX:BLT
|
Capital Expenditures
-NZ$569k
|
CAGR 3-Years
28%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
Capital Expenditures
-NZ$8.6m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Rua Bioscience Ltd
NZX:RUA
|
Capital Expenditures
-NZ$1.2k
|
CAGR 3-Years
90%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
|
G
|
Greenfern Industries Ltd
NZX:GFI
|
Capital Expenditures
-NZ$532.5k
|
CAGR 3-Years
25%
|
CAGR 5-Years
-231%
|
CAGR 10-Years
N/A
|
|
Cannasouth Ltd
Glance View
Cannasouth Ltd. is a biopharmaceutical, research and development company, which develops medicinal cannabis products. The firm focuses on the commercial development of the medically beneficial attributes of cannabinoid compounds such as Cannabidiol (CBD), Tetrahydrocannabinol (THC) and associated chemical structures that are produced by the cannabis plant.
See Also
What is Cannasouth Ltd's Capital Expenditures?
Capital Expenditures
-345.2k
NZD
Based on the financial report for Dec 31, 2023, Cannasouth Ltd's Capital Expenditures amounts to -345.2k NZD.
What is Cannasouth Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-19%
Over the last year, the Capital Expenditures growth was 0%. The average annual Capital Expenditures growth rates for Cannasouth Ltd have been -59% over the past three years , -19% over the past five years .
You don't have any saved screeners yet
